TNF and neoplasm: As an early effect, TNF-α induces an increased uptake of the simultaneously administered alkylating agent into the tumor under ILP, accompanied with its important antiangiogenetic effects, leading to delayed selective destruction of tumor-associated vessels and subsequent tumor regression.